Capital One Investing’s Merck MRK Stock Holding History

Capital One Investing’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$406K	Buy	5,035 +42	+0.8%	+$3.37K	0.09%	135
2019 Q2	$399K	Sell	4,993 -42	-0.8%	-$3.22K	0.1%	124
2019 Q1	$399K	Sell	5,035 -89	-2%	-$6.66K	0.11%	127
2018 Q4	$374K	Buy	+5,124	New	+$362K	0.13%	99

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital One Investing's MRK Position: Q3 2019 in Review

Capital One Investing increased its Merck (MRK) stake by 0.84% in Q3 2019, buying an estimated $3.37K and bringing the position to 5,035 shares worth $406K. The position accounts for 0.09% of the portfolio, ranked #135.

Capital One Investing first reported a position in MRK in Q4 2018 and has held it in 4 quarters since. 2,306 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

Capital One Investing held 5,035 shares of Merck worth $406K as of Q3 2019.
Capital One Investing bought 42 Merck shares in Q3 2019, an estimated $3.37K.
Merck made up 0.09% of Capital One Investing's portfolio in Q3 2019, its #135 holding.
Capital One Investing first reported a position in Merck in Q4 2018 and has held it in 4 quarters since.
2,306 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Capital One Investing's 13F filing for Q3 2019, filed 14 Nov 2019.